Opportunity to join the NICE CG181 guideline committee
NICE are currently recruiting healthcare professionals for a NICE guideline committee to develop guidance for cardiovascular disease prevention. Apply by Tuesday 8 February 2022 at 5pm.
NICE are currently recruiting healthcare professionals for a NICE guideline committee to develop guidance for cardiovascular disease prevention. Apply by Tuesday 8 February 2022 at 5pm.
Shahed Ahmad, Helen Williams, and Nick Linker discuss the importance of cholesterol management and the role of the pathway in CVD Prevention, in a blog for HEART UK.
Congratulations to our 3 lucky winners
There are certain foods that can help maintain healthy cholesterol levels, so for National Cholesterol Month, Lynne Garton, Dietetic Adviser at HEART UK has shared five of the best.
This National Cholesterol Month, Team Loch Duart is taking part in the 'Great Cholesterol Challenge', as they collectively travel the 641-mile distance from their home at Badcall Bay in Northwest Scotland to our HEART UK HQ in Maidenhead.
This World Heart Day, we are proud to be launching our report on ‘The Future of CVD Care in an Evolving System’.
NICE is recommending a new medicine for cholesterol as an option for people who have already had a stroke or heart attack and are not responding to other cholesterol-lowering treatments.
Stakeholders can comment until 13 October on the most wide-ranging and comprehensive review NICE has ever carried out. The public consultations cover proposed changes to the way NICE develops recommendations across its health technology evaluation programmes and proposals to clarify the topic selection and routing criteria used to determine what treatments, devices or diagnostics are selected for NICE guidance development.
Thanks to the effort of HEART UK, ambassadors and supporters thousands of toddlers will be screened for an inherited gene that can cause early heart disease as part of a new national pilot programme.
Over the next two years, 30,000 children across England will be assessed using a heel prick blood test to identify if they have a ‘faulty gene’ which causes familial hypercholesterolaemia (FH).